MIPEP-TNFRSF19 Fusion FISH Probe
The MIPEP-TNFRSF19 Fusion FISH Probe is used to confirm a fusion of the MIPEP and TNFRSF19 genes. The fusion of the MIPEP and TNFRSF19 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MIPEP-TNFRSF19-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MIPEP-TNFRSF19-20-AQAQ | 20 (40 μL) | 200 μL |
|
MIPEP Gene Summary
The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
Gene Name: Mitochondrial Intermediate Peptidase
Chromosome: CHR13: 24304327 -24463587
Locus: 13q12.12
TNFRSF19 Gene Summary
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is highly expressed during embryonic development. It has been shown to interact with TRAF family members, and to activate JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
Gene Name: TNF Receptor Superfamily Member 19
Chromosome: CHR13: 24144508 -24250244
Locus: 13q12.12
Gene Diseases
The MIPEP TNFRSF19 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|